Life Semantics, a local digital healthcare company, said that it would present a digital drug pipeline next Wednesday.
In a corporate conference, Life Semantics plans to introduce its MyData business, which uses the company's digital health business platform and service platform in healthcare and Insurtech.
In detail, the company plans to present digital healthcare and Insurtech business models such as digital health business platforms "Life Record," a cloud-based digital health-only software as a Service-as-a-Service (SaaS)/Backend-as-a-Service (BaaS), and 'Life Record AI' to support patient decisions.
Particularly, the company will unveil its medical device software for cancer management and respiratory rehabilitation, which has been acquired through many years of clinical research.
Medical device software, which has recently attracted attention as a third-generation new drug and also called digital therapeutics, is expected to receive systematic support from the government.
"We hope that this digital health business conference will be a meaningful time to answer questions about Life Semantics' digital health business strategy and the world's most popular digital treatment products, and to find new business plans with various business partners," Life Semantics CEO Song Seung-jae said.
<© Korea Biomedical Review, All rights reserved.>